Efficacy of RTS,S/AS01E Only Seen in Baseline Parasitemic and Not Baseline Aparasitemic <i>Plasmodium falciparum</i>-Exposed, Drug-Treated Kenyan Adults
Authors
Laina D. Mercer (ORCID: https://orcid.org/0000-0002-2517-8900)
Cynthia Lee (ORCID: https://orcid.org/0000-0003-2615-7420)
Efficacy of RTS,S/AS01E Only Seen in Baseline Parasitemic and Not Baseline Aparasitemic Plasmodium falciparum-Exposed, Drug-Treated Kenyan Adults
Laina D. Mercer, Cynthia Lee, Lucas Otieno, Karen Ivinson et al.
Citations
1 citations
Journal
The Journal of Infectious Diseases
Topics
Malaria Research and Control
Field-Weighted Citation Impact (FWCI)
1.88
article
Efficacy of RTS,S/AS01E Only Seen in Baseline Parasitemic and Not Baseline Aparasitemic Plasmodium falciparum-Exposed, Drug-Treated Kenyan Adults
Laina D. Mercer, Cynthia Lee, Lucas Otieno, Karen Ivinson, Hoseah Miima Akala, Michael Raine, Scott Gregory, Ruth Wasuna, Irene Onyango, Peter Sifuna, John J. Aponte, Christian F. Ockenhouse, Mary Omondi, Ben M. Andagalu, June Otieno, Nathanial K. Copeland, Emily Locke, Elke S. Bergmann‐Leitner, Christopher Gast, Solomon Otieno, Marc Lievens, Amos Onditi, Roselyne Oyugi, Hema Pindolia, Salome Chira, Stellah Kevyne Amoit
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
The Journal of Infectious DiseasesVol. 232(3)
Institutions
Program for Appropriate Technology in Health (US), International HIV/AIDS Alliance (GB), International AIDS Vaccine Initiative (US), United States Army Medical Research Directorate - Africa (KE), Kenya Medical Research Institute (KE), GlaxoSmithKline (Belgium) (BE), Seattle University (US), Walter Reed Army Institute of Research (US)
Funders
Bill and Melinda Gates Foundation, GlaxoSmithKline